C3i names Song business development executive in Asia

Monday, July 16, 2012 10:57 AM

C3i, which provides service desk support and business process outsourcing (BPO) services for the life sciences industry, has appointed Jonathan Song business development executive in Asia.

C3i recently opened an operations center in Dalian, China to address the IT support needs of pharmaceutical companies doing business in the main Asian markets. Song will support C3i's strategy to expand its clinical and commercial solutions to pharmaceutical, biotechnology and clinical research organizations in Asia.

Song has 20 years of pharmaceutical and healthcare experience in China and the U.S., both in industry and agency, including positions at Merck and Sinopharm.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs